Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

NCT02753699

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Novartis Investigative Site La Jolla, California, United States
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Ventura, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 119 locations
View Trial Details
Completed

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

NCT01183169

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Ventura, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 75 locations
View Trial Details
Completed

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

NCT01559844

Conditions
Adenocarcinoma, Blood-Borne Infections, Bronchial Diseases, +29 more
Locations
  • UCLA Medical Center-The Pfleger Liver Institute Los Angeles, California, United States
  • UC San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

NCT01330316

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • 1220.48.0004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1220.48.0091 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
  • 1220.48.0011 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1220.48.0018 Boehringer Ingelheim Investigational Site Oceanside, California, United States
View all 87 locations
View Trial Details
Completed

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

NCT01492426

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • The Kirklin Clinic Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Va Long Beach Healthcare System Long Beach, California, United States
  • Medical Associates Research Group San Diego, California, United States
View all 91 locations
View Trial Details
Completed

Hepatitis C Translating Initiatives for Depression Into Effective Solutions

NCT01143896

Conditions
Behavior, Behavioral Symptoms, Blood-Borne Infections, +11 more
Locations
  • Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock Little Rock, Arkansas, United States
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO St Louis, Missouri, United States
  • Michael E. DeBakey VA Medical Center, Houston, TX Houston, Texas, United States
View Trial Details

Related conditions